Mercaptopurine 62484-1020-04

Package NDC

62484-1020-04

Manufacturer: Nova Laboratories, Ltd
Dosage Form: Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: September 8, 2025
Listing Expires: December 31, 2026
Application: NDA205919

Need to source Mercaptopurine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Mercaptopurine	20 mg/mL

Drug Class

Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

62484-1020-04Selected

1 BOTTLE in 1 CARTON (62484-1020-4) / 100 mL in 1 BOTTLE (62484-1020-3)